HK1055914A1 - Methods and vaccines for providing in ovo protection against turkey rhinotracheitis - Google Patents

Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Info

Publication number
HK1055914A1
HK1055914A1 HK03108313A HK03108313A HK1055914A1 HK 1055914 A1 HK1055914 A1 HK 1055914A1 HK 03108313 A HK03108313 A HK 03108313A HK 03108313 A HK03108313 A HK 03108313A HK 1055914 A1 HK1055914 A1 HK 1055914A1
Authority
HK
Hong Kong
Prior art keywords
vaccines
methods
providing
protection against
turkey rhinotracheitis
Prior art date
Application number
HK03108313A
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22954857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1055914(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1055914A1 publication Critical patent/HK1055914A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18311Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK03108313A 2000-11-21 2003-11-14 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis HK1055914A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25216200P 2000-11-21 2000-11-21
PCT/US2001/051207 WO2002045745A2 (en) 2000-11-21 2001-11-13 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Publications (1)

Publication Number Publication Date
HK1055914A1 true HK1055914A1 (en) 2004-01-30

Family

ID=22954857

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108313A HK1055914A1 (en) 2000-11-21 2003-11-14 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Country Status (25)

Country Link
US (2) US20030054016A1 (ja)
EP (1) EP1345658B1 (ja)
JP (1) JP2004536780A (ja)
KR (1) KR20030055314A (ja)
CN (1) CN100379452C (ja)
AR (1) AR031405A1 (ja)
AT (1) ATE361120T1 (ja)
AU (2) AU4342602A (ja)
BG (1) BG107826A (ja)
BR (1) BR0115507A (ja)
CY (1) CY1106707T1 (ja)
CZ (1) CZ20031419A3 (ja)
DE (1) DE60128264T2 (ja)
DK (1) DK1345658T3 (ja)
ES (1) ES2284717T3 (ja)
HK (1) HK1055914A1 (ja)
HR (1) HRP20030508A2 (ja)
HU (1) HUP0302343A2 (ja)
MX (1) MXPA03004432A (ja)
NZ (1) NZ526556A (ja)
PL (1) PL365848A1 (ja)
PT (1) PT1345658E (ja)
WO (1) WO2002045745A2 (ja)
YU (1) YU38503A (ja)
ZA (1) ZA200304762B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115287270B (zh) * 2022-10-09 2023-01-06 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) B亚型禽偏肺病毒传代致弱株及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
CA2156423A1 (en) * 1993-02-26 1994-09-01 Mark D. Cochran Recombinant fowlpox viruses and uses thereof
US6221361B1 (en) * 1995-01-19 2001-04-24 Syntro Corporation Recombinant swinepox virus
FR2750866B1 (fr) * 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
EP0848956A1 (en) 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
FR2758986B1 (fr) * 1997-01-31 1999-04-30 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
AU2001237016A1 (en) 2000-02-29 2001-09-12 Wyeth In ovo protection against infectious bronchitis

Also Published As

Publication number Publication date
US7348012B2 (en) 2008-03-25
MXPA03004432A (es) 2003-08-19
KR20030055314A (ko) 2003-07-02
PT1345658E (pt) 2007-08-09
NZ526556A (en) 2006-06-30
DE60128264T2 (de) 2008-01-10
AU2002243426B2 (en) 2007-05-17
PL365848A1 (en) 2005-01-10
CZ20031419A3 (cs) 2004-02-18
ATE361120T1 (de) 2007-05-15
WO2002045745A2 (en) 2002-06-13
CN1486206A (zh) 2004-03-31
CN100379452C (zh) 2008-04-09
ZA200304762B (en) 2005-03-30
US20060034868A1 (en) 2006-02-16
US20030054016A1 (en) 2003-03-20
ES2284717T3 (es) 2007-11-16
EP1345658B1 (en) 2007-05-02
HRP20030508A2 (en) 2004-08-31
AR031405A1 (es) 2003-09-24
BG107826A (bg) 2004-02-27
CY1106707T1 (el) 2012-05-23
JP2004536780A (ja) 2004-12-09
DK1345658T3 (da) 2007-09-17
HUP0302343A2 (hu) 2003-10-28
YU38503A (sh) 2006-05-25
AU4342602A (en) 2002-06-18
WO2002045745A3 (en) 2002-11-28
EP1345658A2 (en) 2003-09-24
DE60128264D1 (de) 2007-06-14
BR0115507A (pt) 2005-09-20

Similar Documents

Publication Publication Date Title
GB0023008D0 (en) Improvements in vaccination
EP1575500A4 (en) MESOTHELIN VACCINE AND MODEL SYSTEMS
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
HUP0202885A3 (en) Vaccines
GB2383937B (en) Seasoning system and method
PL365598A1 (en) Vaccines
EP1410284A4 (en) VERIFICATION SYSTEM ON POSTAL SENDING
AU5695701A (en) Salmonella vaccine materials and methods
HUP0105392A3 (en) Enhanced vaccines
GB9804121D0 (en) Anti-angiogenic vaccines: materials and methods relating thereto
GB0025327D0 (en) Electrionic Mail system and method
EP1075184A4 (en) ACTIVE VACCINATION COMPOSITIONS AND METHODS
GB9901254D0 (en) Vaccines
IL151039A0 (en) In ovo protection against infectious bronchitis
AU9567201A (en) Vaccine composition and stabilisation method
HU0102389D0 (en) Ibdv stran for in ovo administration
GB2387273A8 (en) Heat-treating methods and systems
HK1055914A1 (en) Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
EP1490105A4 (en) MULTIPLE AND MULTIVALENT DNA VACCINES IN OVO
GB2347984B (en) Protector for use in protecting an elongated member
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
HUP0203831A3 (en) Vaccination against canine herpesvirus infection and vaccines
GB0004533D0 (en) Vaccines
GB2406710B (en) Heat-treating methods and systems
HK1047766A1 (zh) 用於胸腺疫苗接種的多肽和方法

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20211116